These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10881155)

  • 1. [Drug package inserts and the adequacy of patient's drug information].
    da Silva T; Dal-Pizzol F; Bello CM; Mengue SS; Schenkel EP
    Rev Saude Publica; 2000 Apr; 34(2):184-9. PubMed ID: 10881155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical information in drug package inserts in India.
    Shivkar YM
    J Postgrad Med; 2009; 55(2):104-7. PubMed ID: 19550054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug package inserts--varying information for the same medicines].
    Storflor JG; Pettersen LC; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2013 May; 133(9):955-9. PubMed ID: 23652143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of German package inserts.
    Fuchs J; Hippius M; Schaefer M
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):8-13. PubMed ID: 16425965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Information Gaps in Package Inserts Cause Insufficient Patient Information on Correct Handling of Transdermal Patches].
    Lampert A; Haefeli WE; Seidling HM
    Dtsch Med Wochenschr; 2019 Mar; 144(5):e36-e41. PubMed ID: 30836398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rx package inserts: redesigned with fewer errors in mind.
    Fass JA; Seamon MJ; Cytacki J
    J Fam Pract; 2007 Jun; 56(6):438-41. PubMed ID: 17543253
    [No Abstract]   [Full Text] [Related]  

  • 7. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medication directions as a source of technical and scientific information].
    Goncalves Sde A; Melo Gd; Tokarski MH; Barbosa-Branco A
    Rev Saude Publica; 2002 Feb; 36(1):33-9. PubMed ID: 11887227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current oral contraceptive use instructions: an analysis of patient package inserts.
    Williams-Deane M; Potter LS
    Fam Plann Perspect; 1992; 24(3):111-5. PubMed ID: 1628713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of antidepressants during breastfeeding: evaluating drug package inserts conformity with science-based bibliographical sources].
    Pizzol TDSD; Moraes CG; Diello MV; Campos PM; Pletsch JT; Giugliani C
    Cad Saude Publica; 2019 Feb; 35(2):e00041018. PubMed ID: 30785486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of pharmacy and therapeutics committee drug evaluation reports.
    Majercik PL; May JR; Longe RL; Johnson MH
    Am J Hosp Pharm; 1985 May; 42(5):1073-6. PubMed ID: 4003418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of over-the-counter medicines’ information and strategies oriented to the community for improving its access and quality.].
    Armando PD; Moscardó MN; Tenllado MI; Uema SAN
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):248-254. PubMed ID: 30734703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patient-oriented package inserts for drugs. Historical overview and current status].
    Van Haecht CH; Vander Stichele R; Bogaert M
    Arch Belg; 1989; 47(5-6):230-55. PubMed ID: 2700065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice.
    Fed Regist; 1982 Sep; 47(173):39249-50. PubMed ID: 10258155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Information regarding adverse drug effects and treatment indications ("package inserts") exemplified by cervistatin (Lipobay)].
    Braun RN; Halhuber MJ; Hitzenberger G
    Wien Med Wochenschr; 2003; 153(3-4):80-2. PubMed ID: 12658968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia.
    Gebran N; Al Haidari K
    Ann Saudi Med; 2006; 26(3):192-9. PubMed ID: 16861873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excessive medical information increase in package inserts.
    Fuchs J; Werner S; Scheunpflug C; Götze EA; Elstermann K; Scheffel K; Domnowski A; Peter G; Hertzsch C; Hippius M
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):781-90. PubMed ID: 21084033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Planning a statistical inquiry for evaluation of patient information].
    Bernardini C; Ambrogi V; Fardella G; Perioli L; Tiralti MC; Ballatori E
    Boll Chim Farm; 1999 Mar; 138(3):57-67. PubMed ID: 10394704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Package inserts for prescribed medicines: what minimum information do patients need?
    Hermann F; Herxheimer A; Lionel ND
    Br Med J; 1978 Oct; 2(6145):1132-5. PubMed ID: 709267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.